Executive Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Executive Wealth Management's AMGN Position: Q4 2024 in Review
Executive Wealth Management increased its Amgen (AMGN) stake by 19% in Q4 2024, buying an estimated $1.35M and bringing the position to 29,005 shares worth $7.56M. The position accounts for 0.59% of the portfolio, ranked #58.
Executive Wealth Management first reported a position in AMGN in Q4 2018 and has held it in 23 quarters since. The position peaked at $8.84M in Q4 2023. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Executive Wealth Management held 29,005 shares of Amgen worth $7.56M as of Q4 2024.
- Executive Wealth Management bought 4,549 Amgen shares in Q4 2024, an estimated $1.35M.
- Amgen made up 0.59% of Executive Wealth Management's portfolio in Q4 2024, its #58 holding.
- Executive Wealth Management first reported a position in Amgen in Q4 2018 and has held it in 23 quarters since.
- Executive Wealth Management's Amgen position peaked at $8.84M in Q4 2023.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Executive Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.